Most people don't link oral illness to significant health problems, but mounting research indicates that mouth bacteria are crucial in systemic diseases including colon cancer and heart disease.

According to a recent Forsyth Institute study, amyloid plaque, a characteristic of Alzheimer's disease, is produced in connection with periodontal (gum) disease.

In their paper, "Microglial cell response to experimental periodontal disease," published in the Journal of Neuroinflammation, Forsyth scientists and their collaborators at Boston University demonstrate that gum disease can lead to changes in brain cells called microglial cells, which are responsible for defending the brain from amyloid plaque.

This plaque is a type of protein that is associated with cell death, and cognitive decline in people with Alzheimer's.

The study provides important insight into how oral bacteria make their way to the brain and the role of neuroinflammation in Alzheimer's disease.

"We knew from one of our previous studies that inflammation associated with gum disease activates an inflammatory response in the brain," said Dr Alpdogan Kantarci, a senior member of staff at Forsyth and a senior author of the study. "In this study, we were asking the question, can oral bacteria cause a change in the brain cells?"

The microglial cells the researchers studied are a type of white blood cell responsible for digesting amyloid plaque. Forsyth scientists found that when exposed to oral bacteria the microglial cells became overstimulated and ate too much.

"They basically became obese," Dr Kantarci said. "They no longer could digest plaque formations."

The finding is significant for showing the impact of gum disease on systemic health. Gum disease causes lesions to develop between the gums and teeth.

The area of this lesion is the size of your palm. Dr Kantarci explained, "It's an open wound that allows the bacteria in your mouth to enter your bloodstream and circulate to other parts of your body." These bacteria can pass through the blood/brain barrier and stimulate the microglial cells in your brain.

Using experimental models of oral bacteria to cause gum disease in a lab, the scientists were able to track periodontal disease progression in experimental models and confirm that the bacteria had travelled to the brain.

They then isolated the brain microglial cells and exposed them to the oral bacteria. This exposure stimulated the microglial cells, activated neuroinflammation, and changed how microglial cells dealt with amyloid plaques.

"Recognising how oral bacteria causes neuroinflammation will help us to develop much more targeted strategies," said Dr Kantarci.

"This study suggests that in order to prevent neuroinflammation and neurodegeneration, it will be critical to control the oral inflammation associated with periodontal disease.

The mouth is part of the body and if you don't take care of oral inflammation and infection, you cannot really prevent systemic diseases, like Alzheimer's, in a reproducible way."

This study is the first time that scientists caused periodontal disease with experimental models-specific bacteria and could study the effects of same-species oral microbiome on the brain.

Having same-species bacteria and cells brings the test closer to replicating what the process looks like in humans.

The research team consisted of Rawan Almarhoumi, Carla Alvarez, Theodore Harris, Bruce J. Paster, and Alpdogan Kantarci of Forsyth, and Christina M. Tognoni, Isabel Carreras, and Alpaslan Dedeoglu of Boston University.